SARS-CoV-2 vaccination associated venous sinus thrombosis in three patients
Open Access
- 5 October 2022
- journal article
- research article
- Published by University of South Bohemia in Ceske Budejovice in Journal of Applied Biomedicine
- Vol. 20 (3), 83-86
- https://doi.org/10.32725/jab.2022.011
Abstract
Introduction: There is increasing evidence that vaccinations against the severe acquired respiratory syndrome coronavirus type-2 (SARS-CoV-2) virus can be followed by venous sinus thrombosis (VST). Here we report on three patients who developed VST shortly after SARS-CoV-2 vaccinations. Case series: An 80-year-old male, a 58-year-old male, and a 34-year-old female developed VST 14 to 24 days after the first dose of an mRNA-based SARS-CoV-2 vaccine. All three patients profited from analgesics, heparinisation, and oral anticoagulation, but made only an incomplete recovery at the time of discharge. Arguments for a causal relationship are: VST was time-linked to vaccination in the three patients; VST was previously reported after SARS-CoV-2 vaccination; SARS-CoV-2 infections can be complicated by VST; and SARS-CoV-2 can be associated with hypercoagulability. The fact that no hypercoagulability occurred in a pilot study after SARS-CoV-2 vaccination and that there has been no evidence of an increased prevalence/incidence of VST after vaccination since the introduction of the SARS-CoV-2 vaccination speak against a causal relationship. Conclusions: SARS-CoV-2 vaccinations can occasionally be followed by a VST. There are more arguments for than against a causal relationship.Keywords
This publication has 18 references indexed in Scilit:
- Cerebral Venous Sinus Thrombosis and Thrombotic Events After Vector-Based COVID-19 VaccinesNeurology, 2021
- COVID‐19 Vaccine‐Associated Cerebral Venous Thrombosis in GermanyAnnals of Neurology, 2021
- Aortic Thrombosis and Acute Limb Ischemia Secondary to COVID HypercoagulabilityCureus, 2021
- SARS-CoV-2 and Plasma HypercoagulabilityCellular and Molecular Bioengineering, 2021
- Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot studyThrombosis Research, 2021
- Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health SystemJournal of Stroke and Cerebrovascular Diseases, 2021
- Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccineActa Neurochirurgica, 2021
- SARS-CoV-2 vaccine-induced cerebral venous thrombosisEuropean Journal of Internal Medicine, 2021
- Cerebral Venous Sinus Thrombosis in COVID-19 Infection: A Case Series and Review of The LiteratureJournal of Stroke and Cerebrovascular Diseases, 2020
- Cerebral Venous Sinus Thrombosis in the COVID-19 PandemicJournal of Neuro-Ophthalmology, 2020